Clinical Trial Update: Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial compares the fluocinolone acetonide intravitreal implant to standardized therapy in non-infectious uveitis, with results on safety an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-infectious Uveitis

Drugs mentioned

• Fluocinolone Acetonide Intravitreal Implant (Retisert) (fluocinolone acetonide intravitreal implant)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Non-infectious Uveitis | Phase 2, Phase 3 | Status: COMPLETED